Suppr超能文献

[1例伴有门静脉侵犯及右肾上腺转移的肝细胞癌经单用优福定治疗后原发肿瘤及转移灶明显缩小]

[A case of hepatocellular carcinoma with portal invasion and right adrenal gland metastasis showing marked contraction of primary tumor and metastasis with treated by UFT alone].

作者信息

Ohkawa S, Itoh Y, Tamai S, Tarao K

机构信息

Dept. of Internal Medicine, Kanagawa Cancer Center.

出版信息

Gan To Kagaku Ryoho. 1994 Jan;21(1):111-4.

PMID:8291906
Abstract

A 79-year-old female with hepatocellular carcinoma with portal invasion and right adrenal gland metastasis was treated by low dose UFT (200 mg/day). Two months after the initiation of UFT administration, CT scan revealed marked contraction of the primary liver tumor and right adrenal metastasis. Serum AFP and PIVKA-II were also reduced, and right flank pain disappeared. Six months later, CT scan and MRI study were performed. The findings of liver and metastatic lesion were the same as in the earlier study, and the liver function and the patient condition were well controlled. This case is probably rare, but suggestive in the choice of treatment for advanced hepatocellular carcinoma.

摘要

一名79岁患有肝细胞癌伴门静脉侵犯及右肾上腺转移的女性患者接受了低剂量优福定(200毫克/天)治疗。开始服用优福定两个月后,CT扫描显示原发性肝肿瘤及右肾上腺转移灶明显缩小。血清甲胎蛋白和异常凝血酶原也有所降低,右侧胁腹疼痛消失。六个月后,进行了CT扫描和磁共振成像检查。肝脏及转移灶的检查结果与早期检查相同,肝功能及患者状况得到良好控制。该病例可能较为罕见,但对晚期肝细胞癌的治疗选择具有一定的启示意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验